Pathophysiological correlations between SARS-CoV-2 and arrhythmogenesis: a literature review.

IF 1.7 Q3 INFECTIOUS DISEASES
GERMS Pub Date : 2024-03-31 eCollection Date: 2024-03-01 DOI:10.18683/germs.2024.1418
Maria Alexandra Junghetu, Elena Bălăşescu, Laurenţiu Mihăiţă Stratan, Daniela Adriana Ion
{"title":"Pathophysiological correlations between SARS-CoV-2 and arrhythmogenesis: a literature review.","authors":"Maria Alexandra Junghetu, Elena Bălăşescu, Laurenţiu Mihăiţă Stratan, Daniela Adriana Ion","doi":"10.18683/germs.2024.1418","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>SARS-CoV-2 represents one of the most extensively researched pathogens in the last decade due to its major impact on humanity. Not only does this viral infection cause respiratory disturbances, but it also generates cardiovascular injury. Cardiac arrhythmias represent one of the main consequences of SARS-CoV-2 infection, but they can also occur in the context of antiviral treatment. Furthermore, arrhythmias do not always seem to be correlated with the severity of the lung injury. However, they represent a poor prognostic factor in terms of mortality, increasing the need for intensive care and the length of hospitalization.</p><p><strong>Methods: </strong>In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 Statement, from September 2022 to October 2023, we conducted this study by examining the literature through the PubMed database using the following keywords: COVID-19, cardiac arrhythmias, and, in terms of study design, observational studies.</p><p><strong>Results: </strong>We initially identified 266 studies across PubMed. After applying the inclusion/exclusion criteria, we managed to include 22 studies in our review.</p><p><strong>Conclusions: </strong>Deducing the pathophysiological mechanisms behind SARS-CoV-2's ability to disrupt the electrical activity of the heart, as well as identifying associated risk factors in patients with SARS-CoV-2 infection, could allow targeted therapeutic interventions to decrease the risk of mortality in hospitalized patients.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 1","pages":"63-76"},"PeriodicalIF":1.7000,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333842/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GERMS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18683/germs.2024.1418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: SARS-CoV-2 represents one of the most extensively researched pathogens in the last decade due to its major impact on humanity. Not only does this viral infection cause respiratory disturbances, but it also generates cardiovascular injury. Cardiac arrhythmias represent one of the main consequences of SARS-CoV-2 infection, but they can also occur in the context of antiviral treatment. Furthermore, arrhythmias do not always seem to be correlated with the severity of the lung injury. However, they represent a poor prognostic factor in terms of mortality, increasing the need for intensive care and the length of hospitalization.

Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 Statement, from September 2022 to October 2023, we conducted this study by examining the literature through the PubMed database using the following keywords: COVID-19, cardiac arrhythmias, and, in terms of study design, observational studies.

Results: We initially identified 266 studies across PubMed. After applying the inclusion/exclusion criteria, we managed to include 22 studies in our review.

Conclusions: Deducing the pathophysiological mechanisms behind SARS-CoV-2's ability to disrupt the electrical activity of the heart, as well as identifying associated risk factors in patients with SARS-CoV-2 infection, could allow targeted therapeutic interventions to decrease the risk of mortality in hospitalized patients.

SARS-CoV-2 与心律失常发生之间的病理生理学关联:文献综述。
简介SARS-CoV-2 是近十年来研究最为广泛的病原体之一,因为它对人类产生了重大影响。这种病毒感染不仅会引起呼吸系统紊乱,还会造成心血管损伤。心律失常是 SARS-CoV-2 感染的主要后果之一,但在抗病毒治疗过程中也会出现心律失常。此外,心律失常似乎并不总是与肺损伤的严重程度相关。然而,就死亡率而言,心律失常是一个不良预后因素,会增加重症监护需求和住院时间:根据《系统综述和荟萃分析首选报告项目 2020 年声明》,从 2022 年 9 月至 2023 年 10 月,我们通过 PubMed 数据库使用以下关键词对文献进行了研究:COVID-19、心律失常,以及研究设计方面的观察性研究:我们在 PubMed 上初步确定了 266 项研究。应用纳入/排除标准后,我们成功地将 22 项研究纳入了综述:结论:SARS-CoV-2 能破坏心脏的电活动,如果能找到其背后的病理生理机制,并确定 SARS-CoV-2 感染患者的相关风险因素,就能采取有针对性的治疗干预措施,降低住院患者的死亡风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
GERMS
GERMS INFECTIOUS DISEASES-
CiteScore
2.80
自引率
5.00%
发文量
36
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信